The global antifungal drug market is projected to reach $17.4 billion by 2027, driven by the increasing prevalence of fungal infections

0

Global Antifungal Drugs Market Outlook

The global market is primarily driven by significant growth in the pharmaceutical sector.

SHERIDAN, WY, Oct. 25, 2022 /EINPresswire.com/ — According to IMARC Group’s latest report, titled Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 The global Antifungal Drugs Market Size Reached US$14.0 Billion in 2021. Looking ahead, IMARC Group expects the market to reach $17.4 billion by 2027, which will show a growth rate (CAGR) of 3.7% over the period 2022-2027. Antifungal or antifungal drugs are used to stop the growth of infection-causing fungi. Such microorganisms can cause tinea, fungal infections, and nail and skin inflammation, which can be treated and treated by administering oral or injectable antifungal drugs. Fungal infections can also lead to diseases of the circulatory and respiratory tract when inhaled. Antifungal drugs can be divided into three classes based on their site of action, including polyenes, azoles, and allylamines. They are used extensively to treat various conditions such as athlete’s foot, candidiasis, ringworm, fungal meningitis and aspergillosis. Currently, antifungal drugs are primarily available in cream, spray, tablet, over-the-counter (OTC), and intravenous (IV) injection forms.

Note: We regularly track the direct impact of COVID-19 on the market as well as the indirect impact of related industries. These observations are integrated into the report.

Request a Free Sample Report: https://www.imarcgroup.com/antifungal-drugs-market/requestsample

Antifungal Drugs Market Trends:

The increasing prevalence of fungal and nosocomial infections around the world creates a positive outlook for the market. Accordingly, the growing demand for effective OTC drugs such as antifungals across the healthcare sector to treat systemic and superficial infections of the skin, eyes, vagina and mouth is driving the market growth. Additionally, the increasing number of drug approvals and widespread adoption of nanotechnology to formulate advanced antifungal drugs that improve patient outcomes support market growth. This is further influenced by the advent of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections that act as a growth-inducing factor. In addition, continuous research and development (R&D) activities in the field of medical sciences to develop novel antifungal drugs in different modes of administration and their availability through multiple distribution channels support the market growth.

Antifungal Drugs Market 2022-2027 Competitive Analysis and Segmentation:

Competitive landscape with key players:

The competitive landscape of the global Antifungal Drugs Market has been studied in the report that contains the detailed profiles of the major market players.

Competitive landscape with key players:

• Abbott Laboratories
• Arcadia Consumer Healthcare Inc.
• Astellas Pharma Inc.
• Bayer AG
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Scynexis Inc.

Key Market Segmentation:

The report has segmented the global antifungal drugs market by drug class, indication and region.

Breakdown by drug class:

• Azoles
• Echinocandins
• Polyenes
• allylamines
• Other

Separation by indication:

• Dermatophytosis
• Aspergillosis
• Candidiasis
• Other

Breakdown by region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, others)
• Europe: (Germany, France, Great Britain, Italy, Spain, Russia, others)
• Latin America: (Brazil, Mexico, others)
• Middle East and Africa

Ask the analyst for customizations and see the full report with TOC and table of figures: https://www.imarcgroup.com/request?type=report&id=3933&flag=C

Key highlights of the report:

• Market performance (2016-2021)
• Market Outlook (2022-2027)
• Industry trends
• Market drivers and success factors
• The impact of COVID-19 on the global market
• Value chain analysis
• Structure of the global market
• Comprehensive mapping of the competitive landscape

If you require specific information that is not currently in the scope of the report, we will provide it as part of the customization.

Browse Related Reports:

Industrial hemp market

Embolic Protection Devices Market

about us

IMARC Group is a leading market research company providing management strategies and market research worldwide. We partner with clients across sectors and geographies to identify their most valuable opportunities, address their most critical challenges, and transform their businesses.

Our offer includes comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts across multiple industries, is dedicated to delivering high-quality data and insights to our clientele, ranging from small and medium-sized businesses to Fortune 1000 companies.

IMARC’s information products cover key market, scientific, economic and technological developments for executives in pharmaceutical, industrial and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and advanced processing methods are at the forefront of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Share.

Comments are closed.